Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2452951rdf:typepubmed:Citationlld:pubmed
pubmed-article:2452951lifeskim:mentionsumls-concept:C0178837lld:lifeskim
pubmed-article:2452951lifeskim:mentionsumls-concept:C0329155lld:lifeskim
pubmed-article:2452951lifeskim:mentionsumls-concept:C0025663lld:lifeskim
pubmed-article:2452951lifeskim:mentionsumls-concept:C0002210lld:lifeskim
pubmed-article:2452951lifeskim:mentionsumls-concept:C0005767lld:lifeskim
pubmed-article:2452951lifeskim:mentionsumls-concept:C2239176lld:lifeskim
pubmed-article:2452951lifeskim:mentionsumls-concept:C1512080lld:lifeskim
pubmed-article:2452951lifeskim:mentionsumls-concept:C0024870lld:lifeskim
pubmed-article:2452951lifeskim:mentionsumls-concept:C2827485lld:lifeskim
pubmed-article:2452951lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:2452951pubmed:issue2lld:pubmed
pubmed-article:2452951pubmed:dateCreated1988-6-16lld:pubmed
pubmed-article:2452951pubmed:abstractTextA prospective survey of primary hepatocellular carcinoma (PHC) was conducted in a rural area of Taiwan using a two-site enzyme immunoassay for alpha-fetoprotein (AFP) in dried blood samples collected on filter paper. Of 1894 men over 40 years of age who were tested, 20 (1%) had AFP levels of greater than 20 ng/ml of blood on screening. Nineteen of these men received ultrasound examinations, and small PHCs were detected in 4 (21%). The remaining 15 cases had other types of hepatobiliary tract diseases, and 6 (40%) were also serum HBsAg positive. They should all be closely followed up by AFP determination and ultrasound examination of the liver. In contrast to the low resection rate of PHC in symptomatic patients who were admitted through the outpatient clinic during the period of this survey, the four cases with small PHC discovered by AFP screening had their tumors successfully removed (5/57 vs. 4/4, p less than 0.005). Our preliminary results showed that this method is a simple, sensitive and convenient assay for AFP and may be used as a first-line screening test in mass population surveillance programs for PHC, particularly in areas where PHC is highly prevalent.lld:pubmed
pubmed-article:2452951pubmed:languageenglld:pubmed
pubmed-article:2452951pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2452951pubmed:citationSubsetIMlld:pubmed
pubmed-article:2452951pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2452951pubmed:statusMEDLINElld:pubmed
pubmed-article:2452951pubmed:monthAprlld:pubmed
pubmed-article:2452951pubmed:issn0106-9543lld:pubmed
pubmed-article:2452951pubmed:authorpubmed-author:HsiaoK JKJlld:pubmed
pubmed-article:2452951pubmed:authorpubmed-author:HSUF KFKlld:pubmed
pubmed-article:2452951pubmed:authorpubmed-author:WuJ CJClld:pubmed
pubmed-article:2452951pubmed:authorpubmed-author:WangS SSSlld:pubmed
pubmed-article:2452951pubmed:authorpubmed-author:ChorSSlld:pubmed
pubmed-article:2452951pubmed:authorpubmed-author:TsaoDDlld:pubmed
pubmed-article:2452951pubmed:authorpubmed-author:LuiW YWYlld:pubmed
pubmed-article:2452951pubmed:authorpubmed-author:LoK JKJlld:pubmed
pubmed-article:2452951pubmed:authorpubmed-author:ChiangJ HJHlld:pubmed
pubmed-article:2452951pubmed:authorpubmed-author:SAROAAlld:pubmed
pubmed-article:2452951pubmed:issnTypePrintlld:pubmed
pubmed-article:2452951pubmed:volume8lld:pubmed
pubmed-article:2452951pubmed:ownerNLMlld:pubmed
pubmed-article:2452951pubmed:authorsCompleteYlld:pubmed
pubmed-article:2452951pubmed:pagination100-4lld:pubmed
pubmed-article:2452951pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2452951pubmed:meshHeadingpubmed-meshheading:2452951-...lld:pubmed
pubmed-article:2452951pubmed:meshHeadingpubmed-meshheading:2452951-...lld:pubmed
pubmed-article:2452951pubmed:meshHeadingpubmed-meshheading:2452951-...lld:pubmed
pubmed-article:2452951pubmed:meshHeadingpubmed-meshheading:2452951-...lld:pubmed
pubmed-article:2452951pubmed:meshHeadingpubmed-meshheading:2452951-...lld:pubmed
pubmed-article:2452951pubmed:meshHeadingpubmed-meshheading:2452951-...lld:pubmed
pubmed-article:2452951pubmed:meshHeadingpubmed-meshheading:2452951-...lld:pubmed
pubmed-article:2452951pubmed:meshHeadingpubmed-meshheading:2452951-...lld:pubmed
pubmed-article:2452951pubmed:meshHeadingpubmed-meshheading:2452951-...lld:pubmed
pubmed-article:2452951pubmed:meshHeadingpubmed-meshheading:2452951-...lld:pubmed
pubmed-article:2452951pubmed:meshHeadingpubmed-meshheading:2452951-...lld:pubmed
pubmed-article:2452951pubmed:meshHeadingpubmed-meshheading:2452951-...lld:pubmed
pubmed-article:2452951pubmed:meshHeadingpubmed-meshheading:2452951-...lld:pubmed
pubmed-article:2452951pubmed:year1988lld:pubmed
pubmed-article:2452951pubmed:articleTitleMass screening of primary hepatocellular carcinoma by alpha-fetoprotein in a rural area of Taiwan--a dried blood spot method.lld:pubmed
pubmed-article:2452951pubmed:affiliationDepartment of Medicine, Veterans General Hospital, Taiwan, Republic of China.lld:pubmed
pubmed-article:2452951pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2452951pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed